U.S. Plans Tariffs up to 100% on Some Brand-Name Drugs

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 7, 2026.

via HealthDay

TUESDAY, April 7, 2026 — The United States is planning new tariffs on some name-brand medicines.

The move could affect drug prices and how medicines are made.

Officials say tariffs could reach as high as 100% on certain imported drugs that are still under patent protection.

But many companies may be able to avoid those higher costs.

The Trump administration proposes that drugmakers who do not invest in U.S. manufacturing or agree to lower their prices could face the highest tariffs, The Wall Street Journal reported.

Companies that commit to building factories in the U.S. could see their tariffs drop to 20%.

If they also agree to match U.S. prices to the lowest prices they offer in other developed countries — also known as “most favored nation” pricing — tariffs could fall to zero.

Officials say the tariffs will take effect in about 120 days, giving large companies time to respond. Smaller companies will have 180 days.

Most big drugmakers have already agreed to the pricing deals.

Officials said they do not expect many companies to end up paying the full 100% tariff.

In addition to the European Union, countries such as Japan, South Korea and Switzerland would face tariffs of about 15%, while the United Kingdom’s would be 10%, The Wall Street Journal said.

Generic drugs are not included in the plan.

The administration says the goal is to bring more drug manufacturing back to the U.S. and lower prices.

The tariffs would be issued under a law tied to national security.

One critic warned this could have downsides, though.

"Tariffs on cutting-edge medicines will increase costs and could jeopardize billions in U.S. investments announced in the last year," Stephen Ubl, president of the drug industry trade group Pharmaceutical Research and Manufacturers of America, told The Wall Street Journal.

Sources

  • The Wall Street Journal, April 2, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-08 01:59

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords